MDR

This page shows the latest MDR news and features for those working in and with pharma, biotech and healthcare.

Merck preps regulatory filings for much-needed antibiotic combo

An independent UK review estimated that by 2050 MDR infections could claim 10 million lives a year and result in a cumulative loss from global output of $100trn. ... rates of multidrug resistant (MDR) strains, the need for new treatment options is

Latest news

Pharma must do more on antibiotic resistance, Davos meeting hears

In particular, more needs to be done to bring forward new drugs for multidrug resistant (MDR) pathogens or ‘superbugs’ - there are currently 28 novel drugs for high-priority pathogens in phase
Pfizer launches antibiotic resistance surveillance website

Meanwhile, Pfizer’s new antibiotic for multidrug resistant (MDR) infections, Zavicefta, was launched in its first European markets earlier this year after the pharma firm paid its developer AstraZeneca $1.58bn
Pfizer launches new antibiotic Zavicefta in UK and Germany

MDR infections are an increasing global threat," said Matteo Bassetti, chief of the infectious diseases Clinic at University of Udine in Italy. ... The availability of Zavicefta is a major step forward for physicians faced with the challenge of treating
AZ slims down again with sale of antibiotics to Pfizer

ATM-AVI is in trials for life-threatening Gram-negative bacterial infections caused by multi-drug resistant (MDR) strains, while CXL has activity against MDR Gram-positive and Gram-negative pathogens.
AZ gets EU green light for new antibiotic Zavicefta

EMA approves combination drug for treatment of multidrug resistant infections. AstraZeneca's new antibiotic for multidrug resistant (MDR) infections - Zavicefta - has been approved for marketing in the EU. ... In 2014 Professor Sally Davies, the UK Chief

More from news
Approximately 4 fully matching, plus 26 partially matching documents found.

Latest Intelligence

Medical device regulation - a risk-based approach to compliance

Simply put, complying with MDR is another stressor for medtechs at an already challenging time, potentially affecting both top- and bottom-line growth. ... It's difficult to estimate just how great the costs associated with MDR implementation will

More from intelligence
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Senior / Principal Medical Writer - MedComms - Home Based / Vari...: Excellent Remuneration Packages

Editorial / Copy Lead – Healthcare Advertising – Central London...: Salary TBC

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Director – Healthcare PR: Salary TBC

Home-based Principal Medical Writer – Medical Comms: Salary TBC

Account Manager, MedicalCommunications/ Healthcare PR: benefits

Editor – Medical Education Agency – Bucks: Salary TBC

Account Manager, Medical Communications and Marketing: £30, 000 – £40, 000 benefits and bonus

Senior Account Director/ Associate Director- Pharma and Life Sci...: Competitive salary and benefits

PR Associate Director – Consumer Health & Beauty: Salary TBC

Project Manager - Medical Communications – South Wales: Excellent Remuneration Package

Editorial/ Medical Director – Med Ed & Comms – Home-based...: Salary TBC

Account Director – London based Medical Communications Agency: Excellent Remuneration Package

Experienced / Senior Account Director - Publications - London: Up to £80, 000 plus great benefits

Hybrid Role - Principal Medical Writer / Account Handler - Publi...: Salary TBC

Senior Medical Writer: Competitive salary and benefits

Freelance Medical Writer - Healthcare Advertising - London: Employment Type:. Type of Job:. Region:. Salary:. 250 to 330 per day

Senior Medical Writer: Salary TBC

Senior Account Manager- Pharma and Life Scienes: Competitive salary and benefits

Project Manager - Digital Healthcare - London: Excellent Remuneration Package

Account Manager / Senior Account Manager - Healthcare Advertisin...: Excellent Remuneration

Account Director, Medical Education: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality: How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA: Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad: Six behaviours separate the good brand teams from the bad...